Goldman SachsGSBUYDec 29, 2017Stock price when the opinion was issued
As of Jul 21, 2026. Market Open.
Different businesses. LLY is a big play in GLP-1 drugs. How will pills effect the injections business? LLY has done a good job of navigating these new pills. GS enjoys increased stock market and IPO businesses. He prefers LLY, which is tied to a secular growth trend, but GS' good times in capturing revenue in this cycle will end.
Mergers are increasing, and banks like GS makes advisory fees from them. Also, the banks have been rallying since oil slumped, and will benefit further from rising interest rates, which appears will happen later this year. Plus, hyperscalers may need to keep borrowing money to keep competing with each other.
The banking industry as a whole is cheap. This is a very special company. Not expensive. Trading at 1.2X Book. Their "fixed business", such as fixed income, interest rates and commodity business, uses a lot of capital. They are one of the few companies that didn't slim down. That’s hurt them in the last several quarters. However, looking at any kind of metric in investment banking, they are amongst the top 5 where you have to be to make a lot of money. A very premier name and continues to have a lot of cache in it. Very low dividend yield of 1.3%.